Effects of lansoprazole and amoxicillin on uptake of [14C]clarithromycin into gastric tissue in rats

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3451-3455

  Endo, H ^a   Yoshida, H ^a   Ohmi, N ^a   Higuchi, S ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CARBON 14; CLARITHROMYCIN; LANSOPRAZOLE; MACROLIDE; PROTON PUMP INHIBITOR;

ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG DISPOSITION; DRUG UPTAKE; GASTRITIS; HELICOBACTER PYLORI; MALE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; RADIOACTIVITY; RAT; STOMACH PH; TISSUE DISTRIBUTION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG INTERACTIONS; DUODENUM; GASTRIC MUCOSA; GASTROINTESTINAL CONTENTS; INJECTIONS, INTRAVENOUS; MALE; OMEPRAZOLE; PENICILLINS; RATS; RATS, WISTAR; STOMACH; TISSUE DISTRIBUTION;

EID: 0035178725     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3451-3455.2001     Document Type: Article

References (24)

1. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori
2. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori
3. The effect of omeprazole on gastric juice viscosity, pH and bacterial counts
4. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones
5. Review article: The treatment of Helicobacter pylori infection
6. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer
7. Amoxicillin for the treatment of Helicobacter pylori infection
8. Acid-peptic disorders
9. General pharmacological studies on AG-1749 Jpn
10. Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats
11. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: Results of a prospective randomized open study
12. Campylobacter pylori in health and disease: An ecological perspective
13. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
14. 2-receptor antagonist famotidine in rats and dogs
15. Physicochemical properties and stability in the acid solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin
16. 2-receptor antagonists upon physiological acid secretory states in animals
17. Helicobacter pylori and peptic ulcer disease
18. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial
19. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats
20. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: A randomized, doubleblind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens
21. Metabolic fate of TE-031 (A-56268) (IX) absorption and excretion in humans (HPLC method)
22. 14C-TE-031 in rats and dogs
23. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori
24. Unidentified curved bacilli on gastric epithelium in active chronic gastritis